These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8605588)

  • 1. Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.
    Pellegrin I; Legrand E; Neau D; Bonot P; Masquelier B; Pellegrin JL; Ragnaud JM; Bernard N; Fleury HJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):438-47. PubMed ID: 8605588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual.
    Montefiori DC; Altfeld M; Lee PK; Bilska M; Zhou J; Johnston MN; Gao F; Walker BD; Rosenberg ES
    J Immunol; 2003 Apr; 170(7):3906-14. PubMed ID: 12646660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1.
    Lathey JL; Pratt RD; Spector SA
    J Infect Dis; 1997 Jan; 175(1):231-2. PubMed ID: 8985228
    [No Abstract]   [Full Text] [Related]  

  • 4. Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.
    Ruppach H; Nara P; Raudonat I; Elanjikal Z; Rübsamen-Waigmann H; Dietrich U
    J Virol; 2000 Jun; 74(12):5403-11. PubMed ID: 10823844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of an HIV-1 transfection-neutralization assay.
    Back NK; Smit L; Hogervorst E; van Wijk AC; Goudsmit J; Tersmette M
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):531-8. PubMed ID: 7513760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.
    Lathey JL; Tsou J; Brinker K; Hsia K; Meyer WA; Spector SA
    J Infect Dis; 1999 Aug; 180(2):344-50. PubMed ID: 10395848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.
    Bunnik EM; Lobbrecht MS; van Nuenen AC; Schuitemaker H
    Virology; 2010 Feb; 397(1):224-30. PubMed ID: 19945135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point.
    Trkola A; Kuster H; Leemann C; Oxenius A; Fagard C; Furrer H; Battegay M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Bonhoeffer S; Günthard HF;
    Blood; 2004 Sep; 104(6):1784-92. PubMed ID: 15187026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia.
    Medina-Ramírez M; Sánchez-Merino V; Sánchez-Palomino S; Merino-Mansilla A; Ferreira CB; Pérez I; González N; Alvarez A; Alcocer-González JM; García F; Gatell JM; Alcamí J; Yuste E
    J Virol; 2011 Jun; 85(12):5804-13. PubMed ID: 21471239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients.
    Lu W; Shih JW; Tourani JM; Eme D; Alter HJ; Andrieu JM
    AIDS; 1993 Nov; 7 Suppl 2():S91-9. PubMed ID: 7909232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms.
    Deshpande S; Patil S; Kumar R; Hermanus T; Murugavel KG; Srikrishnan AK; Solomon S; Morris L; Bhattacharya J
    Retrovirology; 2016 Aug; 13(1):60. PubMed ID: 27576440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A functional model of the central epitope of the V3 loop of HIV-1 gp120 when complexed with antibodies].
    Shchelkanov MIu; Iaroslavtseva NG; Emel'ianov AV; Sakhuriia IB; Abélian AV; Verevochkin SV; Kozlov AP; Karamov EV
    Mol Biol (Mosk); 1998; 32(6):1062-74. PubMed ID: 9929887
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies.
    Deshpande S; Patil S; Kumar R; Shrivastava T; Srikrishnan AK; Murugavel KG; Koff WC; Chakrabarti BK; Bhattacharya J
    Retrovirology; 2016 Jun; 13(1):41. PubMed ID: 27307004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the antibody response in acute HIV-1 infection.
    Aasa-Chapman MM; Hayman A; Newton P; Cornforth D; Williams I; Borrow P; Balfe P; McKnight A
    AIDS; 2004 Feb; 18(3):371-81. PubMed ID: 15090788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.
    Panther LA; Coombs RW; Zeh JE; Collier AC; Corey L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):303-13. PubMed ID: 9525430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.
    Skrabal K; Saragosti S; Labernardière JL; Barin F; Clavel F; Mammano F
    J Virol; 2005 Sep; 79(18):11848-57. PubMed ID: 16140761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India.
    Makhdoomi MA; Singh D; Nair Pananghat A; Lodha R; Kabra SK; Luthra K
    Virology; 2016 Dec; 499():105-113. PubMed ID: 27643887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.
    Pilgrim AK; Pantaleo G; Cohen OJ; Fink LM; Zhou JY; Zhou JT; Bolognesi DP; Fauci AS; Montefiori DC
    J Infect Dis; 1997 Oct; 176(4):924-32. PubMed ID: 9333150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
    Iuliano R; Forastieri G; Brizzi M; Mecocci L; Mazzotta F; Ceccherini-Nelli L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(5):408-14. PubMed ID: 9170414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.